Author:
Yue Rongcai,Zhao Ling,Hu Yaohua,Jiang Peng,Wang Shuping,Xiang Li,Liu Wencong,Zhang Weidong,Liu Runhui
Funder
NCET Foundation, NSFC
Global Research Network for Medicinal Plants (GRNMP)
King Saud University
Shanghai Engineering Research Center for the Preparation of Bioactive Natural Products
Scientific Foundation of Shanghai China
National Major Project of China
National Key Technology R&D Program
Subject
Drug Discovery,Pharmacology
Reference67 articles.
1. Benefit-risk assessment of leflunomide: an appraisal of leflunomide in rheumatoid arthritis 10 years after licensing;Alcorn;Drug Safety,2009
2. Uric acid provides an antioxidant defense in humans against oxidant-and radical-caused aging and cancer: a hypothesis;Ames;Proceedings of the National Academy of Sciences of the United States of America,1981
3. Urinary tryptophan metabolites in rheumatoid arthritis and some other diseases;Bett;Annals of the Rheumatic Diseases,1966
4. Rheumatoid arthritis;By;Lancet,2010
5. Chemokines and chemokine receptors as novel therapeutic targets in rheumatoid arthritis (RA): inhibitory effects of traditional Chinese medicinal components;Chen;Cellular & Molecular Immunology,2004
Cited by
40 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献